Yasuo Imanishi
- Nephrology top 0.1%
- Parathyroid Disorders and Treatments 93
- Dialysis and Renal Disease Management 9
-
- Bone health and osteoporosis research 25
- Bone and Joint Diseases 11
-
- Vitamin D Research Studies 19
- Oncology top 2%
- Bone health and treatments 44
- Nutrition and Dietetics top 1%
- Magnesium in Health and Disease 10
-
- Genetic Syndromes and Imprinting 20
- Co-authors
- Masaaki InabaYoshiki NishizawàEiji IshimuraSenji OkunoShinsuke YamadaTomoyuki YamakawaAkimitsu MiyauchiTakami Miki
- Journals
- New England Journal of Medicine (1 paper)Physical Review Letters (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Yasuo Imanishi
168 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Nephrology 2.9k
- Orthopedics and Sports Medicine 577
- Pathology and Forensic Medicine 713
- Oncology 1.1k
- Nutrition and Dietetics 595
Countries citing papers authored by Yasuo Imanishi
This map shows the geographic impact of Yasuo Imanishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Imanishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Imanishi more than expected).
Fields of papers citing papers by Yasuo Imanishi
This network shows the impact of papers produced by Yasuo Imanishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Imanishi. The network helps show where Yasuo Imanishi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasuo Imanishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 13 | |
| 6 | 2020 | 24 | |
| 7 | 2019 | 11 | |
| 8 | A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF BUROSUMAB, AN ANTI-FGF23 ANTIBODY, IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH) | 2018 | 1 |
| 9 | 2018 | 13 | |
| 10 | 2018 | 5 | |
| 11 | 2014 | 27 | |
| 12 | 2014 | 34 | |
| 13 | [Magnesium disorder in metabolic bone diseases]. | 2012 | 2 |
| 14 | [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis]. | 2006 | 1 |
| 15 | [Strontium Ranelate as a new therapeutic agent for osteoporosis]. | 2005 | 1 |
| 16 | 2005 | 26 | |
| 17 | FGF-23 is a circulating factor that is elevated in oncogenic osteomalacia and X-linked hypophosphatemic rickets. | 2002 | 8 |
| 18 | 2002 | 35 | |
| 19 | 2002 | 10 | |
| 20 | Involvement of polyamines in the proliferation of bovine parathyroid cells. | 1995 | 4 |
About Yasuo Imanishi
Yasuo Imanishi is a scholar working on Nephrology, Orthopedics and Sports Medicine and Oncology, having authored 177 papers that have together received 4.9k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (93 papers), Bone health and treatments (44 papers), Bone health and osteoporosis research (25 papers), Genetic Syndromes and Imprinting (20 papers), Vitamin D Research Studies (19 papers), Bone and Joint Diseases (11 papers), Magnesium in Health and Disease (10 papers) and Dialysis and Renal Disease Management (9 papers). The work is most often cited by research in Nephrology (2.9k citations), Orthopedics and Sports Medicine (577 citations) and Pathology and Forensic Medicine (713 citations). Yasuo Imanishi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masaaki Inaba, Yoshiki Nishizawà, Eiji Ishimura, Senji Okuno, Shinsuke Yamada, Tomoyuki Yamakawa, Akimitsu Miyauchi, Takami Miki, Keisuke Kobayashi and Andrew Arnold. Their work appears in journals such as New England Journal of Medicine, Physical Review Letters and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.